m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
Abstract Both N6-methyladenosine (m6A) RNA modification and microRNAs (miRNAs) are common regulatory mechanisms for gene post-transcription by modulating mRNA stability and translation. They also share the same 3′-untranslated regions (UTRs) regions for their target gene. However, little is known ab...
Main Authors: | Benheng Qian, Ping Wang, Donghong Zhang, Lianpin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-021-00552-7 |
Similar Items
-
Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients.
by: Ping Wen, et al.
Published: (2014-01-01) -
Reciprocal repression between Fgf8 and miR-133 regulates cardiac induction through Bmp2 signaling
by: Carmen Lopez-Sanchez, et al.
Published: (2015-12-01) -
Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
by: Ying Li, et al.
Published: (2016-01-01) -
The Changes Of Heart MiR-1 And MiR-133 Expressions Following Physiological Hypertrophy Due To Endurance Training
by: Mohammad Fathi, et al.
Published: (2020-09-01) -
CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA
by: Bing Yao, et al.
Published: (2022-06-01)